EurekAlert! In the Spotlight

This month, we're turning our attention to Breast Cancer Awareness Month, a time dedicated to increasing awareness, supporting early detection, and highlighting the ongoing research shaping the future of breast cancer treatment and prevention.

Unveiling breast cancer’s metabolic landscape: A new perspective on targeted therapies

Compuscript Ltd
Peer-Reviewed Publication

Breast cancer remains the most prevalent malignancy among women worldwide, posing a critical challenge to global health. Amid the complexities of this disease, an emerging focus on metabolic reprogramming has shed light on novel treatment avenues. A newly published review delves into the intricate alterations in glucose, lipid, and amino acid metabolism that drive breast cancer progression and explores promising therapeutic strategies designed to exploit these metabolic dependencies.

Journal: Genes & Diseases
Funder: National Science Foundation for Young Scientists of China, Excellent Youth Talent Pool of Army Medical University (China), National Science Foundation for Young Scientists of China, Chongqing Major Medical Research Program (Joint Program of Chongqing Municipal Health Commission and Science and Technology Bureau of China), Chongqing Clinical Diagnosis and Treatment Center of Breast Cancer (China), Military Key Clinical Specialty (China)

Welcome to In the Spotlight, where each month we shine a light on something exciting, timely, or simply fascinating from the world of science.

Latest News Releases

Unveiling breast cancer’s metabolic landscape: A new perspective on targeted therapies

Dual-laser strategy revolutionizes breast cancer photothermal therapy

American Medical Association adopts new policy to help women reduce risk of developing breast cancer

Patients are opting in for 10 years of breast cancer treatment

Study: How adding AI may improve mammography screenings

Novel imaging strategy detects multiple sub-types of triple negative breast cancer

NRG Oncology study shows the addition of regional nodal irradiation does not decrease rates of invasive breast cancer recurrence in patients whose axillary nodes convert from positive to negative following neoadjuvant chemotherapy